Vaccine trials against COVID-19 are leading the effort before studies begin in children. This white paper describes the challenges facing COVID-19 pediatric clinical trials from protocol to planning of pediatric sites.

Key takeaways:

  • Why COVID-19 vaccine trials may be necessary for children in addition to ongoing adult trials.
  • What protocols are currently in place for pediatric trials and how that affects COVID-19 pediatric trials.
  • How to plan for pediatric sites in order to ensure safety for trial participants, staff, and other related entities.